TickerFactsScreenerDevelopers

Gossamer Bio, Inc. (GOSS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$5.75M2018: -$51.04M2019: -$144.83M2020: -$176.36M2021: -$188.89M2022: -$187.03M2023: -$159.16M2024: -$3.47M2025: -$171.27M-$171.27M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$171.27M-4838.5%
2024-$3.47M+97.8%
2023-$159.16M+14.9%
2022-$187.03M+1.0%
2021-$188.89M-7.1%
2020-$176.36M-21.8%
2019-$144.83M-183.7%
2018-$51.04M-788.5%
2017-$5.75M—